New Jersey is getting upward of 2.6 million antigen test kits that could produce results in 15 minutes as to whether or not someone has COVID-19, Gov. Phil Murphy said Monday.

The state will get 170,000 of these BinaxNOW nasal swab test kits, being developed by Abbott Labs, within the next two weeks, according to Murphy. The test kits will be delivered in batches over a 12-week period.

“This could be a game-changer,” said the governor, who credited the White House and President Donald Trump for getting the kits. “When you do the math, it’s just shy of doubling our testing capacity.”

Abbott Labs unveiled the new test just before Labor Day weekend on Aug. 26, which it hailed as an effective tool to quickly get a handle on new cases of the virus to prohibit it from turning into a full-blown outbreak.

The tests were approved by the Food and Drug Administration over the summer. Health care workers are required to report the test results to the U.S. Center for Disease Control and Prevention, and other public health officials, Abbott said.

Test sensitivity – or the ability to correctly identify those who have the virus – is 97.1 percent, according to Abbott Labs, based on a test of 102 participants. Test specificity – or the ability to identify those who do not have the virus – is 98.5 percent.

Many reopening plans for businesses call for not allowing employees to return to physical premises until they can produce a negative test result. A complimentary smartphone app, known as NAVICA, will enable users to display such results to their school or employer.

“We intentionally designed the BinaxNOW test and NAVICA app so we could offer a comprehensive testing solution to help Americans feel more confident about their health and lives,” Abbott Labs President and Chief Executive Officer Robert Ford said in an August statement.

The BinaxNOW test uses a card that collects the test specimen via a nasal swab, and “no equipment is required to process samples or read test results,” reads a statement from Abbott.

“In addition, minimal chemical reagents are required, which lessens exposure to biohazardous materials and improves safety for those administering the test,” the statement continues.

Murphy touted the test could be deployed into COVID-19 hotspot areas “such as we’re seeing in Ocean County.”

And, he said it could go toward schools: Colleges and universities, which are operating with a limited on-campus presence, and pre-K through 12th grade, which are operating in a hybrid model of in-person and remote learning.

“It will be keeping things that are open, open,” he said.

The state is logging record-high numbers of new COVID-19 cases out of Ocean County—more than 3,600 in the past six days according to New Jersey Commissioner of Health Judith Persichilli. A third of them come out of Lakewood, she said Monday, which has one of the largest communities of Orthodox Jews in the nation. State health officials have worried the influx of people celebrating the High Holy Days – Yom Kippur and Rosh Hashanah – could further fuel the spike.

Persichilli said the state health department is sending several contact tracers to Ocean County this week, in addition to increasing testing capacity.

Last week, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, praised how the Murphy administration has handled its reopening and its response to the pandemic since March. Because of that, Fauci said the state would be in a position that it could continue with business reopenings as the colder months approach and a second wave of outbreaks looms that could potentially coincide with the flu season.

New Jersey’s current testing capacity is between 30,000 and 35,000 COVID-19 tests a day, according to Persichilli.